Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.
Weichenthal M, Mangana J, Gavrilova I, Lugowska I, Shalamanova GK, Kandolf L, Chiarion-Sileni V, Mohr P, Karanikolova TS, Teterycz P, Espinosa E, Schnecko P, Cheng P, Bender M, Jiang S, Burke T, Ascierto PA, Gogas H, Rodas IM, Rutkowski P, Schadendorf D, Dummer R, For The EUMelaReg Consortium.
Weichenthal M, et al. Among authors: jiang s.
Cancers (Basel). 2024 Oct 22;16(21):3558. doi: 10.3390/cancers16213558.
Cancers (Basel). 2024.
PMID: 39517999